Mary Ann E. Moore - Nov 8, 2024 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: EVP, GC, Chief Admin Off & Sec
Signature: /s/ Mary Ann E. Moore
Stock symbol: MD
Transactions as of: Nov 8, 2024
Transactions value $: -$129,728
Form type: 4
Date filed: 11/12/2024, 05:00 PM
Previous filing: Jun 4, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	-$130K	-8.11K	-5.63%	$16.00	136K	Nov 8, 2024	Direct	F1
holding	MD	Common Stock						15.7K	Nov 8, 2024	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $16.00 to $16.03 for a weighted average sales price of $16.00. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
F2	The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $16.00 to $16.03 for a weighted average sales price of $16.00. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.

The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.